Peri-implantitis and extracellular matrix antibodies: A case-control study

Area of Science:

• Immunology
• Periodontology
• Biomaterials Science

Background:

• Peri-implantitis is a growing concern in dental implantology.
• Understanding the immunological factors contributing to peri-implantitis is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the presence of autoantibodies against extracellular matrix (ECM) molecules in patients with peri-implantitis.
• To compare antibody levels between patients with peri-implantitis and those with healthy peri-implant environments.

Main Methods:

• A case-control study design was employed.
• Patients were categorized into peri-implantitis and healthy control groups.
• Enzyme-linked immunosorbent assay (ELISA) was used to detect antibodies to specific ECM components, including collagens (types I, III, IV, V), laminin, and fibronectin.

Main Results:

• A statistically significant higher prevalence of antibodies to type III collagen (CIII) was observed in the peri-implantitis group (28.57%) compared to the healthy control group (9.52%).
• No significant differences were found for antibodies against other tested ECM molecules.

Conclusions:

• The findings suggest a potential role for anti-ECM antibodies, specifically anti-CIII, in the pathogenesis of peri-implantitis.
• Larger studies with diverse designs are warranted to validate these results and explore the clinical implications of anti-ECM antibodies in peri-implantitis.